Price will move north of 20 cents prior to FDA approval.
Will probably head towards 30c imo.
The current market cap of $265 mill per annum is an insult. This will probably be the annual sales that Sofdra does alone in the USA.
The move will be rapid and will happen as usual when least expected.
Reminds me of Botanix at 6 cents once the original FDA filing was completed.
Ann: NDA Resubmission Accepted and Approval Date Confirmed, page-82
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.8¢ | 27.8¢ | $2.808M | 9.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2857 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 77213 | 2 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.3¢ |
Change
-0.005 ( 2.72 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 30.5¢ | 27.8¢ | 3452172 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| BOT (ASX) Chart |